ArticleGut and liver2023

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas.

Ting-Yuan Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.